Blueprint Medicines Corporation
BPMC · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $122 | $102 | $89 | $55 |
| Short-Term Investments | $454 | $513 | $645 | $709 |
| Receivables | $80 | $78 | $66 | $85 |
| Inventory | $13 | $14 | $13 | $15 |
| Other Curr. Assets | $33 | $36 | $42 | $40 |
| Total Curr. Assets | $702 | $743 | $855 | $904 |
| Property Plant & Equip (Net) | $98 | $101 | $104 | $109 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $277 | $0 | $143 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $396 | $59 | $241 | $48 |
| Total NC Assets | $494 | $437 | $345 | $300 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,196 | $1,180 | $1,200 | $1,204 |
| Liabilities | – | – | – | – |
| Payables | $1 | $7 | $5 | $5 |
| Short-Term Debt | $58 | $57 | $58 | $127 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $2 | $64 | $64 | $4 |
| Other Curr. Liab. | $190 | $133 | $131 | $108 |
| Total Curr. Liab. | $251 | $261 | $258 | $244 |
| LT Debt | $65 | $412 | $413 | $626 |
| Deferred Rev, NC | $0 | $202 | $8 | $8 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $75 |
| Other NC Liab. | $538 | $7 | $207 | $6 |
| Total NC Liab. | $603 | $620 | $629 | $640 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $82 | $85 | $88 |
| Total Liabilities | $853 | $881 | $887 | $883 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,407 | -$2,407 | -$2,357 | -$2,301 |
| AOCI | -$3 | -$4 | -$1 | -$4 |
| Other Equity | $2,752 | $2,709 | $2,671 | $2,625 |
| Total Equity | $342 | $299 | $313 | $320 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,196 | $1,180 | $1,200 | $1,204 |
| Net Debt | $1 | $367 | $382 | $698 |